(Wednesday) 8:00 AM - 9:00 AM PDT
7550 1H, 10 W Dr Suite 400
8 AM PDT (LIVE event)
Have you prioritized the best emerging technologies to transform therapeutic development? Will the connected lab drive scientific innovation? What role should AI and the internet-of-things play to revolutionize pharmaceutical
Have you prioritized the best emerging technologies to transform therapeutic development?
Will the connected lab drive scientific innovation? What role should AI and the internet-of-things play to revolutionize pharmaceutical R&D? How will your talent need to evolve?
There were already profound changes taking place in life sciences R&D and the pandemic forced business and suppliers to adapt at an even more accelerated pace. Research, driven by technological advances and the continued path towards developing precision medicines is changing the concept of what the lab is.
As life science executives face new challenges, they are focused on transformational initiatives to outsource, automate, and integrate game changing technologies while applying innovative thinking to their Lab of the Future design. Finding the right partner to help create an ideal environment for scientists to innovate and collaborate internally and externally will be key to deliver the best possible treatments to patients faster and cost effectively.
Click here to register and discover:
- Strategies pharmaceutical industry leaders are applying to accelerate their pipeline
- Emerging technologies to address capability gaps for next-generation therapeutics
- Innovations to ensure seamless integration of Lab instruments and IT infrastructure
- Opportunities to rethink leveraging the combination of automation, the cloud, augmented reality, and outsourcing
- Trends where strategic partners are resolving R&D challenges
Hear how executives are applying new thinking into the R&D lab that fosters creativity and innovation to accelerate discovery and development of new medicines.
Frost & Sullivan
Featured Industry Speakers:
Andreas Huhmer PhD
Global Vertical Marketing,
Thermo Fisher Scientific
Global Lead Data and Digital, ARD,
Head of Protein Analytical Chemistry – Quality Control,
In Cooperation with:
Dennis joined Frost & Sullivan in 2021 as Senior Consultant, Transformational Health.
He attained his PharmD at the University of Michigan and his MBA at Drexel University.
He brings with him over 20 years’ of Life Science Marketing experience and has an extensive knowledge of Healthcare marketing, gained at Pfizer, Johnson & Johnson and Hoffman-La Roche.
His experience base covers a broad range of sectors from Pharmaceuticals, Biopharmaceuticals and Pharmacy Benefits Management. His particular expertises are in Marketing Strategy, Competitive Intelligence and Regulatory.